FLT3 and acute myeloid leukemia: For AML with FLT3-ITD, it has been reported that various FLT3 kinase inhibitors synergistically enhanced cytotoxic effects of the PI3K/Akt pathway inhibitors, including GDC-0941 and MK-2206 [44, 45].